Safety Study of a Sensitive Sensual Touch and Personal Lubricant
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01271036 |
|
Recruitment Status :
Completed
First Posted : January 6, 2011
Results First Posted : March 4, 2014
Last Update Posted : March 4, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Inadequate Lubrication | Device: Formula PD-F-7716 | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 124 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Official Title: | A Single-Center, Medically Supervised, Safety Evaluation Study of a Sensitive Sensual Touch and Personal Lubricant Product in Couples |
| Study Start Date : | December 2010 |
| Actual Primary Completion Date : | January 2011 |
| Actual Study Completion Date : | January 2011 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Formula PD-F-7716
Apply a dime-size amount on each application site as instructed during the 1-week study period
|
Device: Formula PD-F-7716
Apply a dime-size amount on each application site as instructed during the 1-week study period
Other Names:
|
- Number of Participants With Physical Irritation Scores [ Time Frame: One week ]Severity of physical irritation scored by the Investigator on a scale from 0 (no irritation) to 6 (presence of lesions). Since a score of 0 is required at baseline for inclusion in the study, this any score represents a change from baseline and the trial is considered baseline-controlled. The number of participants with physical irritation scores after one week was recorded (along with categorical severity).
- Number of Participants Reporting Subjective Irritation - Genital Application 1 [ Time Frame: One week ]Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating. The sensations included itching, burning, stinging, tingling, warming, and cooling. The number of participants with subjective irritation scores after one week was recorded.
- Number of Participants Reporting Subjective Irritation - Genital Application 2 [ Time Frame: One week ]Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating. The sensations included itching, burning, stinging, tingling, warming, and cooling. The number of participants with subjective irritation scores after one week was recorded.
- Number of Participants Reporting Subjective Irritation - Neck Application 1 [ Time Frame: One week ]Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating. The sensations included itching, burning, stinging, tingling, warming, and cooling. The number of participants with subjective irritation scores after one week was recorded.
- Number of Participants Reporting Subjective Irritation - Neck Application 2 [ Time Frame: One week ]Participants were asked to rate specific sensations they experienced during each application at each site (genital and neck) on a five-point categorical severity scale from mild to excruciating. The sensations included itching, burning, stinging, tingling, warming, and cooling. The number of participants with subjective irritation scores after one week was recorded.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Normal, healthy adults in a stable, monogamous, ongoing heterosexual relationship with current partner for at least 6 months
- Subjects comfortable discussing sensitive topics such as personal hygiene, menstruation and sexuality
- At least one partner in the couple has sensitive skin per protocol-defined criteria
- Able to read and understand English
- Voluntarily signs an Informed Consent document after the trial has been explained
- Willing to follow all study procedures, including birth control requirements
Exclusion Criteria:
- Any medical or mental health history or condition, or use of any product, drug or medication that per protocol (or in the opinion of the Investigator) might compromise the participant's safety or the analysis of results
- Participation as a research subject within timelines dictated by protocol
- Participants with relationships or employment outside protocol-defined parameters
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01271036
| United States, Colorado | |
| Thomas J Stephens & Associates, Inc. | |
| Colorado Springs, Colorado, United States, 80915 | |
| Study Director: | Sherryl Frisch | Johnson & Johnson Consumer and Personal Products Worldwide |
| Responsible Party: | Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. |
| ClinicalTrials.gov Identifier: | NCT01271036 |
| Other Study ID Numbers: |
KOYNAP0010 |
| First Posted: | January 6, 2011 Key Record Dates |
| Results First Posted: | March 4, 2014 |
| Last Update Posted: | March 4, 2014 |
| Last Verified: | September 2013 |
|
Lubricating Agents Personal Lubricant |
|
Hypersensitivity Immune System Diseases |

